Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0149871 (
deep vein thrombosis
)
12,364
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Thalidomide is increasingly being used due to its effectiveness in the treatment of a variety of dermatologic conditions refractory to other treatments. Although thalidomide's side effects have been well-documented in the literature since its entry in the 1950s, some of the risks associated with its use are still being discovered. Recently, increased incidence of venous thrombosis following thalidomide use has been reported in the treatment of diseases with disease-related thrombotic risks, such as malignancy and lupus with antiphospholipid antibody syndrome, as well as concomitant therapy with chemotherapy and/or systemic corticosteroids. We report a case of
deep venous thrombosis
(
DVT
) and pulmonary embolus (PE) following thalidomide use in a patient with leprosy (erythema nodosum leprosum,
ENL
) who was concurrently treated with prednisone, as well as a review of relevant literature. Our findings substantiate an increase in risk for thrombosis following thalidomide use in the dermatology and non-cancer clinical setting.
...
PMID:Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature. 1966 16
Thalidomide, previously banned owing to the issues of teratogenicity is being used and tested for a variety of dermatological and non dermatological conditions. The drug has been approved for the management of
ENL
and Multiple myeloma. The drug is commonly known to produce adverse effects like peripheral neuropathy and constipation.
Deep vein thrombosis (DVT)
is one of the serious adverse effects seen with thalidomide use, especially in malignancies and is relatively uncommon in non cancer settings like
ENL
. Here we report a case of
DVT
induced after 8 months of use of thalidomide in a young patient of 22 years age suffering from
ENL
. The case also highlights the problems faced in the management of refractory
ENL
and the treatment of
DVT
in the setting of multiple drug interactions and financial constraints.
...
PMID:Thalidomide induced deep venous thrombosis in a case of steroid dependent erythema nodosum leprosum- a management conundrum. 2852 5